Showing results (181-190 of 206) with videos related to
Sort By:
Pageof 21
Frontiers in Pharmacology|July 5, 2022
Incorporation of Hydrophilic Macrocycles Into Drug-Linker Reagents Produces Antibody-Drug Conjugates With Enhanced in vivo PerformanceNick Evans, Ruslan Grygorash, Paul Williams, et al.Annals of the Rheumatic Diseases|December 13, 2019
High genetic risk score is associated with early disease onset, damage accrual and decreased survival in systemic lupus erythematosusSarah Reid, Andrei Alexsson, Martina Frodlund, et al.Science Advances|January 28, 2022
Multi-principal elemental intermetallic nanoparticles synthesized via a disorder-to-order transitionMingjin Cui, Chunpeng Yang, Sooyeon Hwang, et al.European Urology|October 29, 2024
What's in a Name? Why Words Matter in Advanced Prostate CancerWilliam K Oh, Neeraj Agarwal, Alan Bryce, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 22, 2013
Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trialJane E Onken, David B Bregman, Robert A Harrington, et al.BMJ Open|December 9, 2020
Study protocol for resolution of organ injury in acute pancreatitis (RESORP): an observational prospective cohort studyAhmed E Sherif, Rory McFadyen, Julia Boyd, et al.Molecular Pharmaceutics|April 21, 2015
In Vitro and In Vivo Evaluation of Cysteine Rebridged Trastuzumab-MMAE Antibody Drug Conjugates with Defined Drug-to-Antibody RatiosPenny Bryant, Martin Pabst, George Badescu, et al.Journal of the National Comprehensive Cancer Network : JNCCN|April 1, 2026
Consensus Recommendations for Disease- and Treatment-Related Fatigue in Patients With Advanced Prostate Cancer: A Modified Delphi PanelStephen J Freedland, William Aronson, Arash Asher, et al.Kidney International Reports|June 30, 2026
Prospective Study of Multiparametric Renal MRI for CKD Progression (AFiRM)Susan Francis, Charlotte E Buchanan, Victoria Chester, et al.Prostate Cancer and Prostatic Diseases|September 22, 2025
Using patient-reported outcomes from the PROCLAIM trial to assess the impact of universal germline genetic testing for prostate cancer patientsNeal D Shore, Christopher M Pieczonka, Sean Heron, et al.Pageof 21